Doctor Gabi Hanna’s journey from Qamishli, in north-west Syria, to leading Lamassu Biotech, a cutting-edge biopharmaceutical company in the United States, is a study in purpose, reinvention, and strategic clarity....
Author: Bob Driscoll
Novel SA53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically-Targeted Cancer Treatment (CLEVELAND, OH) – Lamassu Biotech, a clinical-stage pharmaceutical company, today announced a significant clinical milestone...
Brothers Recognized for Their Pioneering Work in Cancer Treatment (CLEVELAND, OH) – Drs. Rabi and Gabi Hanna, two brothers who immigrated to the United States, now making pioneering strides in...